Opsin II 6015
NDC 63083-6015, Opsin II, liquid, from Professional Complementary Health Formulas.
- Product NDC
- 63083-6015
- Status
- Listed
- Labeler
- Professional Complementary Health Formulas
- Dosage form
- LIQUID
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63083-6015 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ONION3 [hp_X]/59mL
- AMBROSIA ARTEMISIIFOLIA WHOLE3 [hp_X]/59mL
- EUPHRASIA STRICTA3 [hp_X]/59mL
- WYETHIA HELENIOIDES ROOT3 [hp_X]/59mL
- NAPHTHALENE4 [hp_X]/59mL
- EPINEPHRINE6 [hp_X]/59mL
- ARUNDO PLINIANA ROOT6 [hp_X]/59mL
- SCHOENOCAULON OFFICINALE SEED6 [hp_X]/59mL
- ARSENIC TRIOXIDE12 [hp_X]/59mL
- HISTAMINE DIHYDROCHLORIDE12 [hp_X]/59mL
- SODIUM CHLORIDE12 [hp_X]/59mL
- TOBACCO LEAF12 [hp_X]/59mL
Pharmacologic classes
Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Allergens [CS]; Catecholamine [EPC]; Catecholamines [CS]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Non-Standardized Food Allergenic Extract [EPC]; Non-Standardized Plant Allergenic Extract [EPC]; Plant Proteins [CS]; Vegetable Proteins [CS]; alpha-Adrenergic Agonist [EPC]; beta-Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63083-6015-2 | 63083601502 | 59 mL in 1 BOTTLE, DROPPER (63083-6015-2) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 63083-6015 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63083-6015 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63083-6015. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.